Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Jpn J Pharmacol ; 85(1): 92-4, 2001 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11243580

RESUMO

The effects of N-nitro-L-arginine-methyl ester (L-NAME) a nitric oxide (NO) synthase inhibitor and L-arginine, a NO precursor, were investigated on lidocaine-induced convulsions. In the first experiment, four groups of mice received physiological saline (0.9%), L-arginine (300 mg/kg, i.p.), L-NAME (100 mg/kg, i.p.) and diazepam (2 mg/kg), respectively. Thirty minutes after these injections, all mice received lidocaine (50 mg/kg, i.p.). In the second experiment, four groups of mice received similar treatment in the first experiment, and 30 min after these injections, all mice received a higher dose of lidocaine (80 mg/kg). L-NAME (100 mg/kg, i.p.) and diazepam (2 mg/kg) significantly decreased the incidence of lidocaine (50 mg/kg)-induced convulsions. In contrast, the L-arginine treatment increased the incidence of lidocaine (80 mg/kg, i.p.)-induced convulsions significantly. These results may suggest that NO is a proconvulsant mediator in lidocaine-induced convulsions.


Assuntos
Anestésicos Locais/toxicidade , Inibidores Enzimáticos/farmacologia , Lidocaína/toxicidade , NG-Nitroarginina Metil Éster/farmacologia , Óxido Nítrico/fisiologia , Convulsões/fisiopatologia , Animais , Anticonvulsivantes/farmacologia , Arginina/farmacologia , Diazepam/farmacologia , Masculino , Camundongos , Óxido Nítrico Sintase/antagonistas & inibidores , Convulsões/induzido quimicamente
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...